| Cell line name |
PLS-1 |
|---|
| Synonyms |
PLS1 |
|---|
| Accession |
CVCL_4U94 |
|---|
| Resource Identification Initiative |
To cite this cell line use: PLS-1 (RRID:CVCL_4U94) |
|---|
| Comments |
Doubling time: ~1.6 days (PubMed=26373732). |
|---|
| Disease |
Recurrent undifferentiated pleomorphic sarcoma (NCIt: C8795)
Undifferentiated pleomorphic sarcoma (ORDO: Orphanet_2023) |
|---|
| Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
|---|
| Sex of cell |
Male |
|---|
| Age at sampling |
80Y |
|---|
| Category |
Cancer cell line |
|---|
| Publications | PubMed=20419128; DOI=10.1371/journal.pone.0010105; PMCID=PMC2855704
Guy Lahat, Quan-Sheng Zhu, Kai-Lieh Huang, Sui-Zhao Wang, Svetlana V. Bolshakov, Jeffrey Jue-Hui Liu, Keila Enitt Torres, Robert R. Langley, Alexander J.F. Lazar, Mien-Chie Hung, Dina Chelouche Lev;
Vimentin is a novel anti-cancer therapeutic target; insights from in vitro and in vivo mice xenograft studies.
PLoS ONE 5:e10105.1-e10105.19(2010) PubMed=26373732; DOI=10.1007/s13277-015-4050-6
Sabrina Mersch, Jasmin C. Riemer, Philipp M. Schlunder, Markus P. Ghadimi, Hany Ashmawy, Birte Mohlendick, Stefan A. Topp, Tanja Arent, Patric Kropil, Nikolas H. Stoecklein, Helmut Erich Gabbert ...Show all 13 authors... , Wolfram Trudo Knoefel, Andreas Krieg; Show fewer authors
Peritoneal sarcomatosis: site of origin for the establishment of an in vitro and in vivo cell line model to study therapeutic resistance in dedifferentiated liposarcoma.
Tumor Biol. 37:2341-2351(2016) |
|---|
| Cross-references |
|---|
| Encyclopedic resources |
Wikidata; Q54947581
|
|---|
| Entry history |
|---|
| Entry creation | 14-Dec-2015 |
|---|
| Last entry update | 21-Mar-2023 |
|---|
| Version number | 5 |
|---|
